Moderna CEO on what's next after success in cancer vaccine
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Moderna CEO Stéphane Bancel announced in Madrid at the European Society for Medical Oncology annual meeting that a decade of research with Merck yielded the first successful Phase 3 study for a customized mRNA-based therapy called intismeran, improving outcomes for melanoma patients.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu